This inventor holds 2 USPTO granted patents. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1994-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chatillon sur Chalaronne, FR (1994)
- Chalaronne, FR (1995)
Company Filing History:
Years Active: 1994-1995
Title: The Innovative Contributions of Patrice Demonchaux
Introduction
Patrice Demonchaux is a notable inventor based in Chatillon sur Chalaronne, France. He has made significant contributions to the field of pharmacology, particularly through his innovative compounds. With a total of 2 patents to his name, his work continues to impact the pharmaceutical industry.
Latest Patents
Demonchaux's latest patents include the development of 5-phenylpyrrolo-1,4-benzoxazine and 5-phenylpyrrolo-1,4-benzothiazine. These pharmacologically active compounds are characterized by their unique formula, which allows for substitutions in the phenyl rings. Additionally, he has worked on 7-fused 2-(piperazinoalkyl) indole derivatives, which are intermediates for compounds that exhibit anti-allergic properties. His research also encompasses processes and intermediates for the preparation of these compounds.
Career Highlights
Patrice Demonchaux is currently associated with Kali-Chemie Pharma GmbH, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in developing new compounds that have potential therapeutic applications.
Collaborations
Throughout his career, Demonchaux has collaborated with esteemed colleagues such as Michel Cottin and Daniel Jasserand. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Patrice Demonchaux's contributions to pharmacology through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile